Jessie Hicks, DO
Internal Medicine · Fort Worth, TXNPI 1811994023
Payments from drug & device makers
Across 23 payments — averaging $14.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$50
- Novo Nordisk$42
- AstraZeneca$41
- GSK$35
- Johnson & Johnson$33
- Amarin Pharma, Inc.$32
- plus $100 from 7 others
What the payments were for
- Food & beverage$333100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 4 | $50 |
| Novo Nordisk | 3 | $42 |
| AstraZeneca | 3 | $41 |
| GSK | 2 | $35 |
| Johnson & Johnson(2 entities) | 2 | $33 |
| Amarin Pharma, Inc. | 2 | $32 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| AbbVie | 1 | $14 |
| Boehringer Ingelheim | 1 | $13 |
| Amgen | 1 | $13 |
| Abbott | 1 | $13 |
| GE HealthCare | 1 | $12 |
How this compares
$333 in reported general payments places this provider in the 50th percentile of 7,675 internal medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Esomeprazole Magnesium | 15 | $2,247 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 44 | $1,635 |
| Gabapentin | 23 | $585 |
| Omeprazole | 19 | $398 |
| Tamsulosin Hcl | 21 | $387 |
| Metoprolol Succinate | 15 | $360 |
| Pantoprazole Sodium | 62 | $332 |
| Atorvastatin Calcium | 47 | $306 |
| Metformin Hcl | 42 | $262 |
| Lisinopril | 50 | $202 |
| Amlodipine Besylate | 42 | $186 |
| Levothyroxine Sodium | 29 | $181 |
| Buspirone Hcl | 17 | $179 |
| Losartan Potassium | 25 | $174 |
| Furosemide | 24 | $160 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Fort Worth
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Muhammad IrfanTomball$30.6M
- Aung NaingHouston$30.6M
- Robert BassSan Antonio$25.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
- Hernan SalazarSan Antonio$18.5M
- Nicholas ShortHouston$17.6M
- Salma SaigerMesquite$16.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.